Reinsurance

How (re)insurers deal with weight-loss drugs

Insurers are no doubt closely monitoring the evolving landscape of development and the usage of weight-loss drugs. Despite the current high costs and unknown long-term unknown factors, they can be a valuable tool in tackling the projected increase of obesity, says Swiss Re’s Ms Natalie Kelly.

Buy Now

Global Nat CAT, reinsurance pricing and MENA

The year got off to a schizophrenic start with the White House announcing that it was withdrawing from the Paris climate accord within days of the news emerging that 2024 proved to be a tipping point that saw planet Earth reach 1.5C above pre-industrial levels. What does it all mean for reinsurance pricing and capacity in the Middle East?

Buy Now